FDA Eager To Authorize More Rapid Antigen COVID-19 Tests
Executive Summary
The US FDA’s diagnostics chief says the agency isn’t seeing many submissions for rapid antigen tests, but is eager to authorize them.
You may also be interested in...
First COVID-19 At-Home Test That Doesn’t Require A Prescription Authorized By The FDA
Ellume Health’s COVID-19 Home Test isn’t just a relatively fast, accurate and easy-to-administer antigen diagnostic, but it’s also available over-the-counter, which greatly expands public access to such tests.
First COVID-19 At-Home Test That Doesn’t Require A Prescription Authorized By The FDA
Ellume Health’s COVID-19 Home Test isn’t just a relatively fast, accurate and easy-to-administer antigen diagnostic, but it’s also available over-the-counter, which greatly expands public access to such tests.
FDA: Rapid Antigen COVID-19 Tests At Risk For False Positives
An alert from the agency warns that the tests, which have become widely used for their speed and portability, carry a risk of false positives.